Urology Xagena

Xagena Mappa
Medical Meeting

Search results for "Keytruda"

Immunotherapy has shown promising results in first and second line treatment of metastatic bladder cancer in two phase II trials presented at the ESMO ( European Society for Medical Oncology ) Congres ...

Anti-PD1 treatment with Pembrolizumab ( Keytruda ) is a promising treatment strategy in many solid tumors. Researchers have reported clinical outcomes of adding Pembrolizumab to men with metastatic ...

Initial results from the phase 1 clinical trial EV-103 were announced. Forty-five patients were evaluated for safety with the combination of the investigational agent Enfortumab Vedotin and the immune ...